Skip to Content

M T13 (Topiramate 100 mg)

Pill with imprint M T13 is White, Round and has been identified as Topiramate 100 mg. It is supplied by Mylan Pharmaceuticals Inc..

Topiramate is used in the treatment of migraine prevention; bulimia; borderline personality disorder; seizures; seizure prevention (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M T13

Topiramate

Imprint:
M T13
Strength:
100 mg
Color:
White
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
lactose anhydrous
silicon dioxide
crospovidone
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
povidone
sodium lauryl sulfate
titanium dioxide
triacetin
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
51079-0728 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide